David S. Miller

Active 1959–2025

186
Papers
37,918
Citations
105
h-index
179
i10-index

Citations

Citations per year for David S. Miller1967: 3 citations1968: 1 citations1969: 4 citations1970: 3 citations1971: 3 citations1972: 6 citations1973: 1 citations1974: 3 citations1975: 1 citations1976: 11 citations1977: 4 citations1978: 4 citations1979: 9 citations1980: 11 citations1981: 9 citations1982: 10 citations1983: 7 citations1984: 8 citations1985: 14 citations1986: 12 citations1987: 20 citations1988: 30 citations1989: 29 citations1990: 32 citations1991: 25 citations1992: 26 citations1993: 50 citations1994: 53 citations1995: 72 citations1996: 54 citations1997: 58 citations1998: 94 citations1999: 114 citations2000: 145 citations2001: 141 citations2002: 176 citations2003: 173 citations2004: 210 citations2005: 193 citations2006: 187 citations2007: 175 citations2008: 245 citations2009: 210 citations2010: 227 citations2011: 286 citations2012: 248 citations2013: 224 citations2014: 281 citations2015: 323 citations2016: 319 citations2017: 369 citations2018: 349 citations2019: 1,034 citations2020: 1,220 citations2021: 1,129 citations2022: 1,048 citations2023: 781 citations2024: 1,259 citations2025: 603 citations2026: 8 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,434 citing papers, 27.2% of this breakdownChina: 1,457 citing papers, 8.9% of this breakdownUnited Kingdom: 1,165 citing papers, 7.2% of this breakdownGermany: 861 citing papers, 5.3% of this breakdownItaly: 795 citing papers, 4.9% of this breakdownCanada: 778 citing papers, 4.8% of this breakdownFrance: 595 citing papers, 3.7% of this breakdownJapan: 538 citing papers, 3.3% of this breakdownNetherlands: 518 citing papers, 3.2% of this breakdownAustralia: 517 citing papers, 3.2% of this breakdownSpain: 477 citing papers, 2.9% of this breakdownIndia: 298 citing papers, 1.8% of this breakdown
0%27.2%Other 23.6%

Fields

  • Medicine59.6%
  • Biochemistry, Genetics and Molecular Biology15.7%
  • Neuroscience7.9%
  • Immunology and Microbiology4.4%
  • Environmental Science2.3%
  • Computer Science1.7%
  • Other8.4%

Topics

  • Drug Transport and Resistance Mechanisms3.1%
  • Alzheimer's disease research and treatments3.1%
  • Endometrial and Cervical Cancer Treatments2.8%
  • Pancreatic and Hepatic Oncology Research2.6%
  • Dementia and Cognitive Impairment Research2.5%
  • Neuroinflammation and Neurodegeneration Mechanisms2.2%
  • Other83.7%

Coauthors

All papers

Open in search
  1. Whole genomes redefine the mutational landscape of pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Felicity Newell, Barsha Poudel, Sarah Song, Darrin F. Taylor, Nick M. Waddell, Scott Wood, Qinying Xu, Jianmin Wu, Mark Pinese, Mark J. Cowley, Hong C. Lee, Marc D. Jones, Adnan Nagrial, Jeremy L. Humphris, Lorraine A. Chantrill, Venessa Chin, Angela Steinmann, Amanda Mawson, Emily S. Humphrey, Emily K. Colvin, Angela Chou, Christopher J. Scarlett, Andreia V. Pinho, Marc Giry-Laterrière, Ilse Rooman, Jaswinder S. Samra, James G. Kench, Jessica A. Pettitt, Neil D. Merrett, Christopher W. Toon, Krishna Epari, Nam Q. Nguyen, Andrew P. Barbour, Nikolajs Zeps, Nigel B. Jamieson, Janet Graham, Simone P. Niclou, Rolf Bjerkvig, Robert Grützmann, Daniela E. Aust, Ralph H. Hruban, Anirban Maitra, Christine A. Iacobuzio–Donahue, Christopher L. Wolfgang, Richard A. Morgan, Rita T. Lawlor, Vincenzo Corbo, Claudio Bassi, Massimo Falconi, Giuseppe Zamboni, Giampaolo Tortora, Margaret A. Tempero, Anthony J. Gill, James R. Eshleman, Christian Pilarsky, Aldo Scarpa, Elizabeth A. Musgrove, John V. Pearson, Andrew V. Biankin, Sean M. Grimmond - Nature 2015 cited by 2,709

  2. Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 cited by 893

  3. Neuropsychiatric symptoms in Alzheimer's disease

    Authors: , , , , , , , , - Alzheimer s & Dementia 2011 cited by 1,133

  4. Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment

    Authors: , , , , , , , , , , - Alzheimer s & Dementia 2015 cited by 839

  5. NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daphne Stewart, Premal H. Thaker, Roberto Vargas, Andrea Wahner Hendrickson, Theresa L. Werner, Emese Zsíros, Mary A. Dwyer, Lisa E. Hang - Journal of the National Comprehensive Cancer Network 2022 cited by 398

  6. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theresa L. Werner, Emese Zsíros, Jennifer L. Burns, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2021 cited by 713

  7. The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Alzheimer s Disease 2017 cited by 551

  8. Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

    Authors: , , , , , , , , , , - The FASEB Journal 2005 cited by 1,283

  9. Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2019 cited by 537

  10. Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 340

  11. Handbook of Mathematical Functions With Formulas, Graphs and Mathematical Tables (National Bureau of Standards Applied Mathematics Series No. 55)

    Authors: , , - Journal of Applied Mechanics 1965 cited by 1,670

  12. Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 147

  13. Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 467

  14. Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms

    Authors: , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia Translational Research & Clinical Interventions 2017 cited by 391

  15. Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Constantine G. Lyketsos, Neuropsychiatric Syndromes Professional Interest Area of ISTAART - Alzheimer s & Dementia 2013 cited by 381

  16. Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancer

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 328

  17. Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vicky Makker, on behalf of the ENGOT-EN5/GOG-3055/SIENDO Investigators, Ignace Vergote, Toon Van Gorp, Isabelle Cadron, Annelore Barbeaux, Nathalie Cornez, Stéphanie Henry, Joseph Kerger, Debbie Debaere, Hannelore Denys, Mansoor Raza Mirza, Amit M. Oza, Lucy Gilbert, Stephen Welch, Michael Kolinsky, Qi Zhou, Jing Wang, Yingjie Yang, Kaijia Tu, Li Wang, Danbo Wang, Ge Lou, Xiaojian Yan, Jiaxin Yang, David Cibula, Jaroslav Klat, Bohuslav Melichar, Michal Zikán, Klaudia Reginacova, Vít Weinberger, Jalid Sehouli, Pauline Wimberger, Dirk Bauerschlag, Fabian Trillsch, Oliver Tomé, Fabienne Schochter, Marco Johannes Battista, Bahriye Aktas, Kristina Luebbe, Mustafa Deryal, George Fountzilas, Athina Christopoulou, Christos Papadimitriou, Flora Zagouri, Limor Helpman, Tamar Safra, Tally Levy, Ilan Bruchim, Ora Rosengarten, Aviad Zick, Giorgio Valabrega, Giovanni Scambia, Giorgia Mangili, Francesco Raspagliesi, Carmela Pisano, Donata Sartori, Ugo De Giorgi, José Alejandro Pérez Fidalgo, César Gómez-Raposo, Ignacio Romero, María Iglesias, Ana Santaballa, Nerea Ancizar, Purificación Estévez, Constanza Maximiano, Alfonso Yubero, Ana Oaknin, Eva Guerra, Lydia Gaba and 52 more - Journal of Clinical Oncology 2023 cited by 71

  18. A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study

    Authors: , , , , , , , , , , , - Gynecologic Oncology 2022 cited by 71

  19. Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease

    Authors: , , , , , , , , , , , , , , , , , - Neurotoxicity Research 2009 cited by 257

  20. Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 2004 cited by 641

  21. Diagnostic criteria for apathy in neurocognitive disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2021 cited by 174

  22. Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - European Psychiatry 2018 cited by 305

  23. Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development

    Authors: , , , , , , , , , , , , , , - Alzheimer s & Dementia Translational Research & Clinical Interventions 2016 cited by 157

  24. The outdoor air pollution and brain health workshop

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - NeuroToxicology 2012 cited by 538